Dexamethasone in Glioblastoma Multiforme Therapy: Mechanisms and Controversies.
GBM
cerebral oedema
dexamethasone
glioblastoma multiforme therapy
pharmacogenomics
Journal
Frontiers in molecular neuroscience
ISSN: 1662-5099
Titre abrégé: Front Mol Neurosci
Pays: Switzerland
ID NLM: 101477914
Informations de publication
Date de publication:
2019
2019
Historique:
received:
16
01
2019
accepted:
26
02
2019
entrez:
16
4
2019
pubmed:
16
4
2019
medline:
16
4
2019
Statut:
epublish
Résumé
Glioblastoma multiforme (GBM) is the most common and malignant of the glial tumors. The world-wide estimates of new cases and deaths annually are remarkable, making GBM a crucial public health issue. Despite the combination of radical surgery, radio and chemotherapy prognosis is extremely poor (median survival is approximately 1 year). Thus, current therapeutic interventions are highly unsatisfactory. For many years, GBM-induced brain oedema and inflammation have been widely treated with dexamethasone (DEX), a synthetic glucocorticoid (GC). A number of studies have reported that DEX also inhibits GBM cell proliferation and migration. Nevertheless, recent controversial results provided by different laboratories have challenged the widely accepted dogma concerning DEX therapy for GBM. Here, we have reviewed the main clinical features and genetic and epigenetic abnormalities underlying GBM. Finally, we analyzed current notions and concerns related to DEX effects on cerebral oedema, cancer cell proliferation and migration and clinical outcome.
Identifiants
pubmed: 30983966
doi: 10.3389/fnmol.2019.00065
pmc: PMC6449729
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
65Références
Annu Rev Neurosci. 1999;22:11-28
pubmed: 10202530
Neuropathol Appl Neurobiol. 1999 Apr;25(2):104-12
pubmed: 10215998
Cancer Res. 1999 Sep 1;59(17):4383-91
pubmed: 10485487
Curr Biol. 1999 Sep 23;9(18):1035-8
pubmed: 10508613
J Neurooncol. 1999;44(3):223-31
pubmed: 10720202
Cancer Res. 2000 Mar 1;60(5):1383-7
pubmed: 10728703
Acta Neuropathol. 2000 Sep;100(3):323-31
pubmed: 10965803
J Clin Neurosci. 2001 Jan;8(1):35-9
pubmed: 11322124
J Neurooncol. 2001 Jan;51(2):105-10
pubmed: 11386406
Carcinogenesis. 2001 Oct;22(10):1715-9
pubmed: 11577014
Neuropathol Appl Neurobiol. 2001 Oct;27(5):384-95
pubmed: 11679090
Nature. 2001 Nov 1;414(6859):105-11
pubmed: 11689955
Front Biosci. 2003 Jan 01;8:e261-9
pubmed: 12456313
Science. 2002 Dec 6;298(5600):1911-2
pubmed: 12471242
Vascul Pharmacol. 2002 Jun;38(6):323-37
pubmed: 12529927
Biochem Biophys Res Commun. 2003 Mar 7;302(2):324-9
pubmed: 12604349
Nat Rev Cancer. 2003 Jul;3(7):489-501
pubmed: 12835669
Tohoku J Exp Med. 1992 Oct;168(2):265-9
pubmed: 1306311
J Lancet. 1961 Feb;81:46-53
pubmed: 13703072
Clin Cancer Res. 2004 Mar 1;10(5):1633-44
pubmed: 15014014
Int J Biochem Cell Biol. 2004 Jun;36(6):1046-69
pubmed: 15094120
J Neurooncol. 2004 May;67(3):305-17
pubmed: 15164986
Acta Neurochir (Wien). 2004 Aug;146(8):841-5
pubmed: 15254806
J Neurol Neurosurg Psychiatry. 2004 Nov;75(11):1632-5
pubmed: 15489404
Neuroscience. 2004;129(4):1011-20
pubmed: 15561416
Mol Cancer. 2004 Dec 08;3(1):36
pubmed: 15588281
Curr Opin Oncol. 2004 Nov;16(6):593-600
pubmed: 15627023
Glia. 2005 Apr 15;50(2):160-7
pubmed: 15685605
Cancer Res. 2005 Apr 1;65(7):2565-71
pubmed: 15805250
Ann Neurol. 1992 May;31(5):481-7
pubmed: 1596083
Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1423-6
pubmed: 16029802
Lab Invest. 2005 Oct;85(10):1189-98
pubmed: 16056241
Proc Natl Acad Sci U S A. 2005 Oct 4;102(40):14344-9
pubmed: 16186508
J Neurosci Res. 1992 Mar;31(3):524-31
pubmed: 1640503
Cancer Invest. 2006 Feb;24(1):35-40
pubmed: 16466990
J Neurooncol. 1991 Apr;10(2):179-85
pubmed: 1654403
Nat Rev Cancer. 2006 Jun;6(6):425-36
pubmed: 16723989
J Neuropathol Exp Neurol. 2006 Jun;65(6):529-39
pubmed: 16783163
J Neurooncol. 2006 Dec;80(3):313-32
pubmed: 16807780
Acta Neuropathol. 2006 Dec;112(6):651-64
pubmed: 16855833
Acta Radiol. 2006 Jul;47(6):585-94
pubmed: 16875337
Nature. 2006 Dec 7;444(7120):756-60
pubmed: 17051156
Oncogene. 2007 Jul 26;26(34):5010-6
pubmed: 17311001
Brain Res. 2007 May 4;1144:33-41
pubmed: 17331483
Arch Pathol Lab Med. 2007 Mar;131(3):397-406
pubmed: 17516742
Neurosurg Focus. 2007 May 15;22(5):E8
pubmed: 17613239
Brain Res. 2007 Aug 8;1162:1-8
pubmed: 17618607
Cancer Res. 2007 Oct 1;67(19):9463-71
pubmed: 17909056
Genes Dev. 2007 Nov 1;21(21):2683-710
pubmed: 17974913
Brain Res. 2008 Jan 16;1189:1-11
pubmed: 18061148
Neuron. 2008 Jan 24;57(2):178-201
pubmed: 18215617
Curr Neurovasc Res. 2008 Feb;5(1):71-81
pubmed: 18289024
Brain Pathol. 2008 Jul;18(3):401-14
pubmed: 18371178
Cancer Invest. 2008 May;26(4):352-8
pubmed: 18443955
Biochem Biophys Res Commun. 2008 Jul 18;372(1):243-8
pubmed: 18485896
Eur J Pharmacol. 2008 Sep 28;593(1-3):1-9
pubmed: 18652821
Future Oncol. 2008 Aug;4(4):525-34
pubmed: 18684063
Science. 2008 Sep 26;321(5897):1807-12
pubmed: 18772396
Neurosci Lett. 2009 Mar 13;452(2):114-8
pubmed: 19135131
Cancer Lett. 2009 Jun 28;279(1):30-8
pubmed: 19217205
J Neurooncol. 2009 May;92(3):317-35
pubmed: 19357959
Brain Res. 2009 Apr 10;1265:1-12
pubmed: 19368818
Brain Res. 2009 Mar 9;1259:1-6
pubmed: 19401176
Curr Cancer Drug Targets. 2009 May;9(3):381-90
pubmed: 19442057
Cancer Cell. 2009 Jun 2;15(6):501-13
pubmed: 19477429
J Clin Neurosci. 2009 Sep;16(9):1226-8
pubmed: 19497751
Acta Neuropathol. 2009 Oct;118(4):469-74
pubmed: 19554337
Science. 2009 Jun 26;324(5935):1670-3
pubmed: 19556499
Mol Cells. 2009 Jul 31;28(1):7-12
pubmed: 19655094
Sci Signal. 2009 Sep 08;2(87):re6
pubmed: 19738203
J Biol Chem. 2009 Nov 20;284(47):32483-92
pubmed: 19759012
J Clin Invest. 2010 Jan;120(1):41-50
pubmed: 20051635
Cancer Lett. 2010 Jun 28;292(2):215-27
pubmed: 20060208
Neurobiol Dis. 2010 Jul;39(1):40-6
pubmed: 20064612
Br J Cancer. 2010 Mar 2;102(5):789-95
pubmed: 20104230
Cancer Cell. 2010 Jan 19;17(1):98-110
pubmed: 20129251
J Biol Chem. 2010 Apr 9;285(15):11188-96
pubmed: 20139089
Neurol Neurochir Pol. 2010 Jan-Feb;44(1):80-6
pubmed: 20358487
J Oncol. 2010;2010:351908
pubmed: 20414463
Anticancer Res. 2010 Nov;30(11):4515-24
pubmed: 21115901
Brain Tumor Pathol. 2011 Feb;28(1):13-24
pubmed: 21221826
J Neurosci. 2011 Mar 30;31(13):4858-67
pubmed: 21451024
J Neurooncol. 2011 Nov;105(2):241-51
pubmed: 21598070
Expert Rev Clin Pharmacol. 2011 Mar;4(2):233-42
pubmed: 21666852
Clin Cancer Res. 2011 Aug 15;17(16):5473-80
pubmed: 21737504
J Clin Oncol. 2011 Dec 1;29(34):4473-4
pubmed: 22025161
Eur J Radiol. 2012 Oct;81(10):2805-10
pubmed: 22100373
Mol Aspects Med. 2012 Oct-Dec;33(5-6):579-89
pubmed: 22387049
J Biol Chem. 2012 Apr 27;287(18):14615-20
pubmed: 22442146
Am J Pathol. 2012 Oct;181(4):1126-41
pubmed: 22858156
Exp Cell Res. 2012 Nov 15;318(19):2417-26
pubmed: 22906859
Anticancer Res. 2012 Oct;32(10):4251-61
pubmed: 23060545
Neuro Oncol. 2012 Nov;14 Suppl 5:v1-49
pubmed: 23095881
J Mol Med (Berl). 2013 Apr;91(4):439-48
pubmed: 23512266
Cancers (Basel). 2011 Jan 27;3(1):461-77
pubmed: 24212625
J Membr Biol. 2014 Jan;247(1):45-55
pubmed: 24240542
Cell Tissue Res. 2014 Mar;355(3):597-605
pubmed: 24352805
Philos Trans R Soc Lond B Biol Sci. 2014 Feb 03;369(1638):20130095
pubmed: 24493743
PLoS One. 2014 Apr 08;9(4):e93264
pubmed: 24714627
Cell. 2014 Apr 10;157(2):447-458
pubmed: 24725410
Science. 2014 May 9;344(6184):634-8
pubmed: 24790029
Med Oncol. 2014 Jun;31(6):985
pubmed: 24838514
Curr Oncol. 2014 Jun;21(3):e493-503
pubmed: 24940109
Nat Rev Neurosci. 2014 Jul;15(7):455-65
pubmed: 24946761
Neuro Oncol. 2014 Oct;16 Suppl 8:viii1-6
pubmed: 25342599
Arch Med Res. 2014 Nov;45(8):610-38
pubmed: 25481827
Front Cell Neurosci. 2014 Dec 12;8:418
pubmed: 25565956
Hum Vaccin Immunother. 2014;10(11):3322-31
pubmed: 25625931
Front Cell Neurosci. 2015 Jan 15;8:467
pubmed: 25642170
Anticancer Res. 2015 Feb;35(2):615-25
pubmed: 25667438
J Cereb Blood Flow Metab. 2015 Jul;35(7):1191-8
pubmed: 25757751
Front Cell Neurosci. 2015 Apr 20;9:152
pubmed: 25941475
Int J Mol Sci. 2015 Apr 30;16(5):9949-75
pubmed: 25941935
Am J Pathol. 2015 Jul;185(7):1820-33
pubmed: 25976245
PLoS One. 2015 Jun 29;10(6):e0131670
pubmed: 26121251
Neuro Oncol. 2016 Jan;18(1):16-26
pubmed: 26188014
J Clin Invest. 2015 Sep;125(9):3335-7
pubmed: 26325031
Gene. 2016 Jan 15;576(1 Pt 2):189-94
pubmed: 26435191
Radiat Oncol. 2015 Oct 31;10:222
pubmed: 26520780
Br J Cancer. 2015 Dec 1;113(11):1642
pubmed: 26625224
J Cereb Blood Flow Metab. 2016 Mar;36(3):513-38
pubmed: 26661240
Steroids. 2016 Jul;111:84-88
pubmed: 26930575
Oncotarget. 2016 May 31;7(22):33440-50
pubmed: 26967052
Brain. 2016 May;139(Pt 5):1458-71
pubmed: 27020328
J Cell Physiol. 2017 Jan;232(1):91-100
pubmed: 27028592
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Expert Opin Investig Drugs. 2016 Aug;25(8):937-56
pubmed: 27170161
Oncotarget. 2016 Sep 13;7(37):59360-59376
pubmed: 27449082
J Cell Physiol. 2017 Sep;232(9):2478-2488
pubmed: 27606467
J Neurosurg Anesthesiol. 2017 Jan;29(1):46-58
pubmed: 27653222
Oncotarget. 2016 Oct 18;7(42):69051-69059
pubmed: 27655705
Oncoscience. 2016 Jul 27;3(7-8):188-202
pubmed: 27713909
Cell Oncol (Dordr). 2017 Feb;40(1):21-32
pubmed: 27766591
Oncotarget. 2017 Mar 14;8(11):18577-18589
pubmed: 28099914
J Cell Physiol. 2018 Jan;233(1):363-370
pubmed: 28262948
Oncotarget. 2017 Jun 13;8(24):38444-38455
pubmed: 28404978
Eur J Pharmacol. 2017 Sep 5;810:70-82
pubmed: 28583430
Mol Cancer. 2017 Jun 7;16(1):100
pubmed: 28592260
Chin Clin Oncol. 2017 Jun;6(3):33
pubmed: 28705010
Curr Neuropharmacol. 2018;16(5):636-643
pubmed: 28707595
Oncotarget. 2017 Jul 8;8(38):63788-63798
pubmed: 28969029
Mol Med Rep. 2018 Feb;17(2):3206-3211
pubmed: 29257313
Brain Sci. 2017 Dec 20;7(12):null
pubmed: 29261148
J Neurosurg. 2018 Dec 1;129(6):1446-1455
pubmed: 29328002
J Neurooncol. 2018 May;137(3):503-510
pubmed: 29349612
Med Oncol. 2018 Jan 31;35(3):27
pubmed: 29387965
Neurol Neurochir Pol. 2018 Aug;52(4):495-504
pubmed: 29588064
Contemp Oncol (Pozn). 2018 Mar;22(1A):81-85
pubmed: 29628799
Oncol Lett. 2018 May;15(5):7595-7602
pubmed: 29740485
Front Oncol. 2018 May 07;8:142
pubmed: 29868469
Semin Cancer Biol. 2018 Dec;53:201-211
pubmed: 30031763
Semin Cancer Biol. 2018 Sep 8;:null
pubmed: 30205139
Front Oncol. 2018 Oct 16;8:448
pubmed: 30386738
Clin Epigenetics. 2019 Jan 17;11(1):11
pubmed: 30654849
Neurosurg Rev. 2019 Jan 23;:null
pubmed: 30673883
J Neurosurg. 1971 Mar;34(3):324-34
pubmed: 4323143
Acta Neuropathol. 1983;60(3-4):223-31
pubmed: 6613532
Biochem Biophys Res Commun. 1995 Mar 8;208(1):432-9
pubmed: 7887961
J Clin Endocrinol Metab. 1993 Nov;77(5):1388-92
pubmed: 8077338
J Cell Biol. 1993 Dec;123(6 Pt 2):1777-88
pubmed: 8276896
Cancer Res. 1977 Feb;37(2):585-94
pubmed: 832280
J Cell Sci. 1996 Feb;109 ( Pt 2):429-35
pubmed: 8838666
Science. 1997 Jul 4;277(5322):55-60
pubmed: 9204896
Am J Pathol. 1997 Sep;151(3):853-7
pubmed: 9284834
Klin Padiatr. 1997 Jul-Aug;209(4):275-7
pubmed: 9293462
J Neurol Neurosurg Psychiatry. 1997 Oct;63(4):520-1
pubmed: 9343136
Eur J Pharmacol. 1998 Jan 12;341(2-3):309-15
pubmed: 9543253
J Cell Biol. 1998 Oct 19;143(2):391-401
pubmed: 9786950
Brain Pathol. 1998 Oct;8(4):667-8
pubmed: 9804375
Brain Res. 1999 Jan 23;816(2):309-16
pubmed: 9878804
J Neurosurg. 1999 Feb;90(2):300-5
pubmed: 9950501